Announcements Trials
Browse Landscape

Phase

Phase 2 43Phase 3 13Phase 4 10Phase 1 3Phase NA 2Phase 1/2 2Phase EARLY_PHASE1 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Non-Small-Cell Lung 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Exercise 439Blood Specimen Collection 333Standard of Care 321Magnetic Resonance Spectroscopy 259Radiotherapy 255Surveys and Questionnaires 245Radiosurgery 245Educational Status 230Methods 229Early Intervention, Educational 218Practice Guidelines as Topic 146Interviews as Topic 146Biopsy 146Surgical Procedures, Operative 135Drug Therapy 133Control Groups 128Acupuncture Therapy 124Therapeutics 110Cyclophosphamide 103Palliative Care 101Counseling 101Resistance Training 95Saline Solution 90Cisplatin 90Magnetic Resonance Imaging 89Radiofrequency Ablation 86Specimen Handling 79Radiotherapy, Intensity-Modulated 79Colonoscopy 79Cognitive Behavioral Therapy 72

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × icotinib × Clear all
NCT03983811 2019-06-12

Adjuvant Chemotherapy With or Without Intercalated Icotinib

Nanfang Hospital, Southern Medical University

Phase NA Unknown
174 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03766490 2019-01-30

Anlotinib Hydrochloride Combined With EGFR TKIs in Advanced Non-small Cell Lung Cancer

The First Affiliated Hospital of Soochow University

Phase NA Unknown
66 enrolled
Thoracic

Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡